Allied Market Research

2024

Large Volume Parenteral (lvp) Market

Large Volume Parenteral (LVP) Market Size, Share, Competitive Landscape and Trend Analysis Report by TREATMENT TYPES : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use. The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market.

GLOBAL LARGE VOLUME PARENTERAL TREATMENT TYPES MARKET ANALYSIS

On the basis of its types, this market can be classified into fluid balance injections, therapeutics injections and nutritious injections. Fluid balance injections supply electrolytes such as sodium chloride and potassium to patients suffering from trauma. Nutrients are supplied to unhealthy patients through intravenous infusion for their better recovery. Therapeutic injections include oncology, vaccines, diabetes and anti-infective administrations.

LARGE VOLUME PARENTERAL GEOGRAPHY MARKET ANALYSIS

On the basis of geography, this market is classified into North America, Europe, Asia-Pacific and rest of the world (RoW). The market for LPV is expected to grow in Asia-Pacific region due to increasing promotion of medical tourism.

COMPETITIVE LANDSCAPE

The major players in this market are Ostuka Pharmaceutical, Teva Pharmaceutical Industries Limited, Kelun Pharma, Cook Pharmica LLC, Patheon Inc., BAG Healthcare, Southwest Pharmaceutical Co. Ltd., Cook Pharmica LLC, Beximco Pharma and Baxter Healthcare Corporation. The companies are planning to come up with new products to meet different therapeutic demands.

HIGH LEVEL ANALYSIS

Porter’s five forces model is strategically analyzed in the report to project current and future market scenarios. The bargaining power of buyers is high due to negligible cost of switching. There exists intense competition and high threat from substitutes in this market. The value chain analysis of the organ transplant immunosuppressant drugs market is dealt strategically. Top wining strategies adopted by the key players competing in this market are critically analyzed through primaries.

KEY BENEFITS

  • Intelligence from key market segments through top investment pockets would help in providing strategic assistance to decision markers. 
  • Analysis of key market players and strategies adopted by them are dealt to give an insight on top contenders in the market
  • This report gives a detailed analysis of drivers and factors limiting market expansion of global large volume parenteral market
  • Projections are made for the by considering current market scenario and future potential
  • Porter’s five forces and SWOT analysis discussed would help in making strategic decisions

Large Volume Parenteral (LVP) Market Report Highlights

Aspects Details
icon_5
By TREATMENT TYPES
  • Fluid Balance Injections
  • Therapeutic Injections
  • Nutritious Injections
icon_6
By GEOGRAPHY
  • North America
  • Europe
  • Asia-Pacific
  • RoW
icon_7
Key Market Players

Novartis, B. Braun, Pfizer, Fresenius, Baxter, Cipla, Sandoz, Hospira, Grifols, Hospira (Pfizer)

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Large Volume Parenteral (LVP) Market

Global Opportunity Analysis and Industry Forecast, 2023-2032